BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19416440)

  • 1. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment.
    Inciardi JA; Surratt HL; Cicero TJ; Beard RA
    Pain Med; 2009 Apr; 10(3):537-48. PubMed ID: 19416440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.
    Inciardi JA; Surratt HL; Kurtz SP; Cicero TJ
    Pain Med; 2007 Mar; 8(2):171-83. PubMed ID: 17305688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of prescription medication diversion among drug dealers.
    Rigg KK; Kurtz SP; Surratt HL
    Drugs (Abingdon Engl); 2012; 19(2):144-155. PubMed ID: 22665955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Determinants of Specific Modes of Prescription Opioid Diversion.
    Cicero TJ; Kurtz SP; Surratt HL; Ibanez GE; Ellis MS; Levi-Minzi MA; Inciardi JA
    J Drug Issues; 2011; 41(2):283-304. PubMed ID: 22287798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "black box" of prescription drug diversion.
    Inciardi JA; Surratt HL; Cicero TJ; Kurtz SP; Martin SS; Parrino MW
    J Addict Dis; 2009 Oct; 28(4):332-47. PubMed ID: 20155603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription opioid abuse among drug-involved street-based sex workers.
    Surratt HL; Inciardi JA; Kurtz SP
    J Opioid Manag; 2006; 2(5):283-9. PubMed ID: 17319260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaboration or coercion? Partnering to divert prescription opioid medications.
    Green TC; Bowman SE; Ray M; Zaller N; Heimer R; Case P
    J Urban Health; 2013 Aug; 90(4):758-67. PubMed ID: 23371052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription opioid use, misuse, and diversion among street drug users in New York City.
    Davis WR; Johnson BD
    Drug Alcohol Depend; 2008 Jan; 92(1-3):267-76. PubMed ID: 17913395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pill counts and pill rental: unintended entrepreneurial opportunities.
    Viscomi CM; Covington M; Christenson C
    Clin J Pain; 2013 Jul; 29(7):623-4. PubMed ID: 23328335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sources of prescription opioids among diagnosed opioid abusers.
    Shei A; Rice JB; Kirson NY; Bodnar K; Birnbaum HG; Holly P; Ben-Joseph R
    Curr Med Res Opin; 2015 Apr; 31(4):779-84. PubMed ID: 25661018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
    Cicero TJ; Ellis MS
    JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abuse of immediate-release opioids and current approaches to reduce misuse, abuse and diversion.
    Nalamachu SR; Shah B
    Postgrad Med; 2022 May; 134(4):388-394. PubMed ID: 30025214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measures to quantify the abuse of prescription opioids: a review of data sources and metrics.
    Secora AM; Dormitzer CM; Staffa JA; Dal Pan GJ
    Pharmacoepidemiol Drug Saf; 2014 Dec; 23(12):1227-37. PubMed ID: 25257660
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.